Simplex Trading
ORIC icon

Simplex Trading’s Oric Pharmaceuticals ORIC Stock Holding History

Simplex Trading’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.87K Buy
700
+300
+75% +$3.41K ﹤0.01% 7457
2025
Q4 		$3.27K Sell
400
-1,800
-82% -$20.7K ﹤0.01% 7642
2025
Q3 		$26K Sell
2,200
-1,100
-33% -$11.6K ﹤0.01% 7104
2025
Q2 		$33K Buy
3,300
+2,000
+154% +$13.4K ﹤0.01% 6318
2025
Q1 		$7K Buy
1,300
+800
+160% +$7K ﹤0.01% 7354
2024
Q4 		$4K Sell
500
-1,800
-78% -$16.5K ﹤0.01% 7771
2024
Q3 		$23K Sell
2,300
-100
-4% -$989 ﹤0.01% 6560
2024
Q2 		$16K Sell
2,400
-3,500
-59% -$31.3K ﹤0.01% 7081
2024
Q1 		$81K Buy
5,900
+5,300
+883% +$62.9K ﹤0.01% 5799
2023
Q4 		$5K Sell
600
-100
-14% -$723 ﹤0.01% 7885
2023
Q3 		$4K Sell
700
-600
-46% -$4.92K ﹤0.01% 7796
2023
Q2 		$10K Buy
1,300
+900
+225% +$5.11K ﹤0.01% 7419
2023
Q1 		$2K Sell
400
-1,000
-71% -$5.23K ﹤0.01% 8500
2022
Q4 		$8K Buy
+1,400
New +$4.73K ﹤0.01% 7740
2022
Q3 		– Sell
-500
Closed -$2K – 10616
2022
Q2 		$2K Buy
500
+200
+67% +$798 ﹤0.01% 9398
2022
Q1 		$1K Buy
300
+200
+200% +$1.8K ﹤0.01% 10121
2021
Q4 		$1K Hold
100
– – ﹤0.01% 10220
2021
Q3 		$1K Hold
100
– – ﹤0.01% 9671
2021
Q2 		$1K Buy
100
+99
+9,900% +$2.17K ﹤0.01% 9848
2021
Q1 		$2K Buy
+1
New +$32 ﹤0.01% 8474

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Simplex Trading's ORIC Position: Q1 2026 in Review

Simplex Trading increased its Oric Pharmaceuticals (ORIC) stake by 172% in Q1 2026, buying an estimated $9.67K and bringing the position to 1,348 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6895.

Simplex Trading first reported a position in ORIC in Q2 2021 and has held it in 12 quarters since. The position peaked at $225K in Q2 2023. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Simplex Trading held 1,348 shares of Oric Pharmaceuticals worth $17.1K as of Q1 2026.
  • Simplex Trading bought 852 Oric Pharmaceuticals shares in Q1 2026, an estimated $9.67K.
  • Oric Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6895 holding.
  • Simplex Trading first reported a position in Oric Pharmaceuticals in Q2 2021 and has held it in 12 quarters since.
  • Simplex Trading's Oric Pharmaceuticals position peaked at $225K in Q2 2023.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.